Patent Armory v. Natus Medical: 3D Sensing Patent Case Dismissed

📄 View Full Report 📥 Export PDF 🔗 Share ⭐ Save

Introduction

In one of 2024’s fastest-resolved patent infringement actions, Patent Armory, Inc. v. Natus Medical Incorporated concluded with a stipulated dismissal with prejudice just 18 days after filing — before substantive litigation could begin. Filed on April 1, 2024, in the U.S. District Court for the Western District of Wisconsin, and closed on April 19, 2024, the case centered on U.S. Patent No. 7,256,899 B1, covering wireless methods and systems for three-dimensional non-contact shape sensing.

The rapid resolution raises critical questions for patent attorneys, IP professionals, and R&D teams: Was this a pre-litigation settlement? A strategic withdrawal? Or a calculated assertion that achieved its objective before the first motion was filed? For stakeholders monitoring 3D sensing patent litigation and non-contact measurement technology disputes, this case offers compact but instructive lessons about modern patent assertion dynamics, venue selection, and the evolving economics of short-duration IP disputes.

📋 Case Summary

Case NamePatent Armory, Inc. v. Natus Medical Incorporated
Case Number3:24-cv-00210 (W.D. Wis.)
CourtU.S. District Court for the Western District of Wisconsin
DurationApril 1, 2024 – April 19, 2024 18 days
OutcomeDismissed with prejudice (Plaintiff)
Patents at Issue
Accused ProductsProducts incorporating wireless 3D non-contact shape sensing capabilities
Legal Representation

Plaintiff’s Counsel: Isaac Rabicoff (Rabicoff Law LLC)

Defendant’s Counsel: Lance E. Wyatt Jr., Neil Joseph McNabnay (Fish & Richardson LLP)

Case Overview

The Parties

⚖️ Plaintiff

Operates as a patent assertion entity (PAE), acquiring and licensing patents across technology sectors, often through targeted litigation.

🛡️ Defendant

Recognized medical device manufacturer specializing in neurology diagnostics and newborn care, developing products with advanced sensing and measurement technologies.

The Patent at Issue

  • Patent Number: US 7,256,899 B1 (Application No. US 11/538,753)
  • Technology Area: Wireless methods and systems for three-dimensional non-contact shape sensing
  • Significance: The ‘899 patent covers foundational wireless 3D sensing methodology applicable across medical devices, industrial measurement systems, and diagnostic imaging — a broad claim footprint with potential reach across multiple product categories.

The Accused Product

The complaint targeted Natus Medical’s products incorporating wireless three-dimensional non-contact shape sensing capabilities. While the specific Natus product line was not detailed in the case record, the accused functionality aligns with diagnostic and neurological measurement tools that employ spatial sensing technology.

🔍

Developing products with 3D sensing?

Check if your technology might infringe this or related patents before launch.

Run FTO Check →

Litigation Timeline & Procedural History

MilestoneDate
Complaint FiledApril 1, 2024
Case ClosedApril 19, 2024
Total Duration18 days

The case was filed in the U.S. District Court for the Western District of Wisconsin — a venue that has historically drawn patent cases given its efficient case management practices. The Western District of Wisconsin is known for expedited scheduling orders and active judicial management, which can pressure parties toward early resolution.

Notably, no substantive motions appear in the case record prior to dismissal. There was no claim construction briefing, no motion to dismiss, and no preliminary injunction proceedings. The parties moved directly to a stipulated dismissal under Federal Rule of Civil Procedure 41(a)(1)(A)(ii), which allows parties to dismiss an action by filing a signed stipulation without requiring court approval.

The 18-day lifecycle is exceptionally brief even by PAE litigation standards, suggesting that either pre-litigation licensing negotiations concluded rapidly, or the parties reached a private resolution immediately upon service of process. No damages figures or licensing terms were disclosed in the public record.

The Verdict & Legal Analysis

Outcome

The case was dismissed with prejudice as to all claims against Natus Medical, and without prejudice as to any counterclaims Natus may have filed against Patent Armory. Each party agreed to bear its own attorneys’ fees, costs, and expenses — a mutual walk-away arrangement standard in confidential settlement structures.

  • Plaintiff’s claims: Dismissed with prejudice (cannot re-file the same claims)
  • Defendant’s counterclaims: Dismissed without prejudice (preserves Natus’s future options)
  • Fee arrangement: Each party bears its own costs

Verdict Cause Analysis

Because the case resolved before any court-issued rulings on validity, claim construction, or infringement, there is no judicial analysis on the merits to examine. The dismissal with prejudice is the operative legal event. This structure is characteristic of a confidential licensing settlement in which the patent holder receives consideration (typically a lump-sum license fee) in exchange for a covenant not to sue and dismissal of the action.

The asymmetric dismissal terms — plaintiff’s claims with prejudice, counterclaims without prejudice — reflect a deliberate negotiation outcome. Natus’s preservation of counterclaim rights suggests its defense team (Fish & Richardson) may have developed invalidity or non-infringement arguments strong enough to secure favorable dismissal terms, or that Patent Armory accepted resolution terms that foreclosed re-litigation risk.

Legal Significance

While this case produced no precedential rulings, several legally significant observations emerge:

  1. No fee-shifting under 35 U.S.C. § 285: The mutual cost-bearing arrangement means neither party pursued, or succeeded in, an “exceptional case” finding — a common defensive objective against PAE plaintiffs
  2. Rule 41(a)(1)(A)(ii) mechanics: The stipulated dismissal pathway bypasses judicial review entirely, reinforcing its utility as a clean exit in IP disputes
  3. Claim preclusion implications: The with-prejudice dismissal bars Patent Armory from asserting the ‘899 patent against Natus in future proceedings — a meaningful defensive win for the medical device company

Industry & Competitive Implications

The three-dimensional non-contact shape sensing space sits at the intersection of medical diagnostics, industrial metrology, and emerging AR/VR spatial computing — a high-value technology area attracting sustained patent assertion activity. US 7,256,899 B1’s wireless sensing claims are potentially relevant to a wide range of medical device, robotics, and measurement product categories.

For Natus Medical, the with-prejudice dismissal provides immediate certainty regarding the ‘899 patent, enabling uninterrupted product development and commercialization. The engagement of Fish & Richardson signals that Natus treats patent defense as a strategic investment, not merely a legal cost center.

For the broader medical device and sensing technology sector, this case reflects an ongoing pattern: PAEs identify patents with broad wireless sensing claims and pursue targeted, short-duration actions designed to generate licensing revenue before costly litigation ensues. Companies operating in 3D sensing, spatial measurement, and non-contact diagnostic technologies should conduct proactive portfolio audits against patents held by entities like Patent Armory.

The case also underscores the continued relevance of Western District of Wisconsin as a patent litigation venue, particularly for disputes where rapid, negotiated resolution is the anticipated endpoint.

⚠️

Freedom to Operate (FTO) Analysis

This case highlights critical IP risks in 3D sensing technology. Choose your next step:

📋 Understand This Case’s Impact

Learn about the specific risks and implications from this litigation.

  • View related patents in the 3D sensing space
  • See which companies are most active in 3D sensing patents
  • Understand claim construction patterns for similar patents
📊 View Patent Landscape
⚠️
High Risk Area

Wireless 3D non-contact shape sensing

📋
Active Assertion

Around US 7,256,899 B1

Proactive Audits

Essential for R&D and IP teams

✅ Key Takeaways

For Patent Attorneys & Litigators

Stipulated dismissal under Rule 41(a)(1)(A)(ii) remains a powerful, court-bypass resolution mechanism in PAE disputes.

Search related case law →

Asymmetric dismissal terms (with/without prejudice) are negotiable and carry significant long-term legal implications.

Explore precedents →

Absence of fee-shifting reflects either pre-§285 resolution or insufficient litigation history to establish exceptionality.

Analyze fee-shifting cases →

Western District of Wisconsin’s efficiency profile can incentivize early settlement.

Benchmark court venues →
For IP Professionals

Patent Armory’s assertion of US 7,256,899 B1 signals active monetization activity around wireless 3D sensing claims — track related continuations or assignments.

Monitor patent portfolios →

In-house teams should evaluate whether the ‘899 patent’s claims create FTO exposure across their product lines.

Assess FTO risk →
🔒
Unlock R&D Team Recommendations
Get actionable design patent strategy steps for product teams, including FTO timing guidance and filing best practices.
Targeted FTO Reviews Design-Around Strategies Proactive Portfolio Audits
Explore Full Analysis in PatSnap Eureka

Frequently Asked Questions

Ready to Strengthen Your Patent Strategy?

Join 18,000+ IP professionals using PatSnap Eureka to conduct prior art searches, draft patents, and analyse competitive landscapes with AI-powered precision.

PatSnap IP Intelligence Team

Patent Research & Competitive Intelligence · PatSnap

This analysis was produced by the PatSnap IP Intelligence Team — a group of patent analysts, IP strategists, and data scientists who work daily with PatSnap’s global patent database of over 2 billion structured data points across patents, litigation records, scientific literature, and regulatory filings.

The team specialises in tracking landmark litigation outcomes, translating complex court rulings into actionable IP strategy, and identifying the competitive intelligence implications for R&D and legal teams. All case analysis is grounded in primary sources: official court records, USPTO filings, and Federal Circuit opinions.

📊 2B+ Patent Data Points 🌍 120+ Countries Covered 🏢 18,000+ Customers Worldwide ⚖️ Global Litigation Database 🔍 Primary Source Verified

References

  1. PACER — Case documents for 3:24-cv-00210
  2. USPTO Patent Full-Text Database — US 7,256,899 B1
  3. Cornell Legal Information Institute — Federal Rule of Civil Procedure 41(a)(1)(A)(ii)
  4. Cornell Legal Information Institute — 35 U.S.C. § 285
  5. PatSnap — IP Intelligence Solutions for Law Firms

This article is for informational purposes only and does not constitute legal advice. All case information is drawn from publicly available court records. For platform capabilities, visit PatSnap.

⚖️ Disclaimer: This article is for informational purposes only and does not constitute legal advice. The analysis presented reflects publicly available case information and general legal principles. For specific advice regarding patent litigation, FTO analysis, or IP strategy, please consult a qualified patent attorney.